UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000013107
Receipt No. R000015289
Official scientific title of the study Examination of the effect that EMLA cream gives for a rocronium dosage time ache.
Date of disclosure of the study information 2014/02/07
Last modified on 2017/08/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Examination of the effect that EMLA cream gives for a rocronium dosage time ache.
Title of the study (Brief title) Examination of the effect that EMLA cream gives for a rocronium dosage time ache.
Region
Japan

Condition
Condition The patient who has an operation under anesthesia in our hospital.
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 When I perform tracheal intubation, the dosage of the muscle relaxant is necessary for general anesthesia. Action time of onset is early as muscle relaxant, and rocuronium which duration of action has a short is generally used now. It is said that rocuronium has a strong pain in the dosage and may be accompanied by body movement in the dosage. I am in danger of an intravenous feeding false withdrawal, a gastric content countercurrent, the aspiration by body movement. Various methods (opioid, the intravenous precedent dosage of the local anesthetic) are performed as a method to reduce a rocuronium dosage time ache. However, a circulation change may become unstable by the precedent drug dosage, and it is difficult to give the precedent dosage for all cases. The EMLA cream which was lidocaine propitocaine combination cream was released in Japan in 2013. This drug has adaptation for painkilling with the laser treatment. It is intended to consider whether you can reduce a rocuronium dosage time ache by applying EMLA cream to skin.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We evaluate it by sharp pain score, a vital change after the rocuronium dosage.
Key secondary outcomes

Base
Study type

Study design
Basic design Parallel
Randomization Randomized
Randomization unit
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Control group: application posterior vein secures a basis from the back of hand to the forearm.
Interventions/Control_2 Emura group: application posterior vein from the EMLA cream back of hand to the forearm 45 minutes before venepuncture
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Planned operation patient under the general anesthesia
Key exclusion criteria The patient who uses a local anesthetic before general anesthesia.
Target sample size 40

Research contact person
Name of lead principal investigator Daisuke Sugiyama
Organization Shinshu University
Division name Department of Anesthesiology and Resuscitology
Address 3-1-1 Asahi, Matsumoto, Nagano
TEL 0263-37-2670
Email sugidai@shinshu-u.ac.jp

Public contact
Name of contact person Daisuke Sugiyama
Organization Shinshu University
Division name Department of Anesthesiology and Resuscitology
Address 3-1-1 Asahi, Matsumoto, Nagano
TEL 0263-37-2670
Homepage URL
Email sugidai@shinshu-u.ac.jp

Sponsor
Institute Shinshu University School of Medicine
Institute
Department

Funding Source
Organization Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 02 Month 07 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 02 Month 07 Day
Anticipated trial start date
2014 Year 02 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 02 Month 07 Day
Last modified on
2017 Year 08 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015289